NCT06589089View on ClinicalTrials.gov

Autologous Hematopoietic Stem Cell Boost Study After CAR-T Therapy

PHASE2RecruitingINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

October 15, 2024

Primary Completion Date

August 31, 2025

Study Completion Date

December 31, 2025

Conditions
Diffuse Large B Cell Lymphoma
Interventions
DRUG

autologous hematopoietic stem cell

Intervention were given myelosuppression occurring that cannot be controlled with other drugs as judged by the investigators

Trial Locations (1)

Unknown

RECRUITING

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai

All Listed Sponsors
lead

Ruijin Hospital

OTHER